Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Nanexa | NANEXA | 21. nov 2024 | 1.31 | +7.79 |
NanoCap Group B | NANOCB | 21. nov 2024 | 6.52 | -3.26 |
NanoEcho | NANECH | 21. nov 2024 | 0.14 | +14.33 |
Nanoform Finland | NANOFS | 21. nov 2024 | 16.34 | +1.62 |
Nanologica | NICA | 21. nov 2024 | 1.73 | +0.29 |
NASDAQ OMX Small Cap Sweden GI | NOMXSCSEGI | 21. nov 2024 | 4 215.66 | +0.26 |
NASDAQ OMX Small Cap Sweden PI | NOMXSCSE | 21. nov 2024 | 2 600.00 | +0.26 |
Nattaro Labs | NATTA | 21. nov 2024 | 0.39 | +36.36 |
Navigo Invest AB | NAVIGOSTAM | 21. nov 2024 | 2.37 | +1.28 |
Navigo Invest Pref | NAVIGOPREF | 21. nov 2024 | 100.50 | 0.00 |
NAXS | NAXS | 21. nov 2024 | 51.40 | -0.77 |
NCAB Group | NCAB | 21. nov 2024 | 56.75 | +1.34 |
NCC A | NCCA | 21. nov 2024 | 159.50 | 0.00 |
NCC B | NCCB | 21. nov 2024 | 157.80 | 0.00 |
Nederman Holding | NMAN | 21. nov 2024 | 219.00 | -3.95 |
NEL | NELO | 21. nov 2024 | 2.94 | -5.10 |
Nelly Group | NELLY | 21. nov 2024 | 27.55 | -2.99 |
Neobo Fastigheter | NEOBO | 21. nov 2024 | 20.25 | +1.33 |
Neola Medical | NEOLA | 21. nov 2024 | 2.72 | +5.43 |
Neovici Holding B | NEOB | 21. nov 2024 | 9.15 | -6.15 |
Nepa | NEPA | 21. nov 2024 | 19.05 | +0.26 |
Net Insight B | NETIB | 21. nov 2024 | 6.77 | +0.74 |
Netel | NETEL | 21. nov 2024 | 13.50 | +3.05 |
NetJobs Group | NJOB | 21. nov 2024 | 0.33 | -4.02 |
New Nordic Healthbrands | NNH | 21. nov 2024 | 15.00 | 0.00 |
New Wave B | NEWAB | 21. nov 2024 | 95.55 | -0.21 |
Newbury Pharmaceuticals | NEWBRY | 21. nov 2024 | 3.52 | -2.76 |
Newlist | NEWL | 21. nov 2024 | 0.10 | -5.00 |
Nexam Chemical Holding | NEXAM | 21. nov 2024 | 4.08 | +0.99 |
Nexar Group | NXAR | 21. nov 2024 | 0.27 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.